Compass Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Compass Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$370K	Buy	5,924 +276	+5%	+$17.4K	0.07%	138
2026 Q2	$325K	Buy	+5,648	New	+$324K	0.06%	147
2025 Q4	–	Sell	-5,237	Closed	-$236K	–	85
2025 Q3	$236K	Buy	+5,237	New	+$245K	0.05%	141
2025 Q2	–	Sell	-3,698	Closed	-$226K	–	183
2025 Q1	$226K	Buy	3,698 +1,500	+68%	+$87.4K	0.06%	144
2024 Q4	$124K	Hold	2,198	–	–	0.03%	180
2024 Q3	$114K	Sell	2,198 -3,632	-62%	-$170K	0.03%	191
2024 Q2	$242K	Sell	5,830 -1,832	-24%	-$82K	0.06%	149
2024 Q1	$416K	Sell	7,662 -5,460	-42%	-$278K	0.1%	120
2023 Q4	$673K	Sell	13,122 -10,931	-45%	-$574K	0.19%	100
2023 Q3	$1.4M	Sell	24,053 -467	-2%	-$28.6K	0.44%	72
2023 Q2	$1.57M	Sell	24,520 -500	-2%	-$33.5K	0.47%	67
2023 Q1	$1.73M	Sell	25,020 -914	-4%	-$64.5K	0.55%	63
2022 Q4	$1.87M	Buy	+25,934	New	+$1.96M	0.61%	58

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Compass Wealth Management's BMY Position: Q3 2026 in Review

Compass Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 4.9% in Q3 2026, buying an estimated $17.4K and bringing the position to 5,924 shares worth $370K. The position accounts for 0.07% of the portfolio, ranked #138.

Compass Wealth Management first reported a position in BMY in Q4 2022 and has held it in 13 quarters since. The position peaked at $1.87M in Q4 2022. 694 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

Compass Wealth Management held 5,924 shares of Bristol-Myers Squibb worth $370K as of Q3 2026.
Compass Wealth Management bought 276 Bristol-Myers Squibb shares in Q3 2026, an estimated $17.4K.
Bristol-Myers Squibb made up 0.07% of Compass Wealth Management's portfolio in Q3 2026, its #138 holding.
Compass Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 13 quarters since.
Compass Wealth Management's Bristol-Myers Squibb position peaked at $1.87M in Q4 2022.
694 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Compass Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.